Against a backdrop of global antibiotic resistance and increasing awareness of the
importance of the human microbiota, there has been resurgent interest in the potential use of …

In this age of technology, the vision of manufacturing industries built of smart factories is not
a farfetched future. As a prerequisite for Industry 4.0, industrial sectors are moving towards …

Virus-like particles (VLPs) are multiprotein structures that mimic the organization and
conformation of authentic native viruses but lack the viral genome, potentially yielding safer …

This multiauthor review article aims to bring readers up to date with some of the current
trends in the field of process analytical technology (PAT) by summarizing each aspect of the …

Promising nanotechnological platforms, based on inorganic nanoparticles and
nanomaterials, have emerged in such fields as targeted drug delivery, bio-and chemical …

The growing biopharmaceutical industry has reached a level of maturity that allows for the
monitoring of numerous key variables for both process characterization and outcome …

Viral infectious diseases threaten human health and global stability. Several vaccine
platforms, such as DNA, mRNA, recombinant viral vectors, and virus-like particle-based …

Abstract The “Pharmaceutical Current Good Manufacturing Practices (CGMPs) for the 21st
Century—A Risk Based Approach” initiative announced by the FDA in August 2002 to …

Biotechnological processes are crucial to the development of any economy striving to
ensure a relevant position in future markets. The cultivation of microorganisms in bioreactors …

Virus-like particles (VLPs) hold tremendous potential as vaccine candidates. These
innovative biopharmaceuticals present the remarkable advantages of closely mimicking the …